QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 08:10 UTC · Public disclosure record

CLXTICKER

Clorox Co.

BULLISH stock

Congress has disclosed 17 buys and 20 sells of CLX (Clorox Co.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

17
Buy
20
Sell
-3
Net
15
Active politicians

Round-trip watch Still on the books

Members who disclosed buying CLX and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.

MemberEntry (last buy)Entry priceNowvs entryStatus
Lisa McClain 2025-10-30 $107.02 $88.00 -17.8% underwater

Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Price & congressional trades
Buy Sell

Fundamentals · FY2027 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Chemicals. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/E
15.43
▼ cheaper than Chemicals (median 23.4)
how it's calculated
P/E = price ÷ earnings per share
$88.00 ÷ $5.70 = 15.43
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
P/B
-273.38
≈ in line with Chemicals (median 3.6)
how it's calculated
P/B = price ÷ book value per share
$88.00 ÷ $-0.32 = -273.38
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

37 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Gilbert Cisneros House SELL ◆ insider divergence · moderate Self · 150 Main Street Trust > Bank of America 2026-05-15 21 days +4.1% $1K–$15K
0.1% of NW
19.0 ↗ filing
Gilbert Cisneros House BUY ◆ insider convergence · moderate Self · 150 Main Street Trust > Bank of America 2025-12-19 21 days +8.0% $1K–$15K
0.1% of NW
28.3 ↗ filing
Gilbert Cisneros House SELL ◆ insider divergence · moderate Self · 150 Main Street Trust > Bank of America 2025-11-12 30 days -0.7% $1K–$15K
0.1% of NW
66.8 ↗ filing
Lisa McClain House SELL ◆ insider divergence · moderate Spouse · Charles Schwab Brokerage Account 924 2025-10-30 2 days 0.0% $1K–$15K
0.1% of NW
33.4 ↗ filing
Lisa McClain House BUY ◆ insider convergence · moderate Spouse · Charles Schwab 401K > Schwab 893 2025-10-30 2 days 0.0% $1K–$15K
0.1% of NW
28.1 ↗ filing
Lisa McClain House BUY ◆ insider convergence · moderate Spouse · Charles Schwab Brokerage Account 924 2025-06-24 50 days +1.7% $1K–$15K
0.1% of NW
63.6 ↗ filing
Jefferson Shreve House SELL ◆ insider divergence · moderate Self · CRT - Standard Unit Trust 2025-04-11 14 days -1.4% $15K–$50K
<0.1% of NW
69.3 ↗ filing
Marjorie Taylor Greene House BUY Self 2022-02-22 2 days — $1K–$15K 75.9 ↗ filing
Lois Frankel House SELL Self 2022-02-07 19 days — $1K–$15K
0.3% of NW
15.7 ↗ filing
Carol Devine Miller House SELL Self 2021-12-14 31 days — $15K–$50K
0.1% of NW
48.0 ↗ filing
Lois Frankel House BUY Self 2021-06-26 0 days — $1K–$15K
0.3% of NW
22.3 ↗ filing
Carol Devine Miller House BUY Spouse 2021-03-04 28 days — $15K–$50K
0.1% of NW
56.6 ↗ filing
Peter Meijer House SELL Self 2021-01-28 6 days — $1K–$15K 75.9 ↗ filing
Dean Phillips House SELL Self 2020-12-18 20 days — $1K–$15K
<0.1% of NW
40.4 ↗ filing
Dean Phillips House BUY Self 2020-09-23 14 days — $1K–$15K
<0.1% of NW
75.9 ↗ filing
Carol Devine Miller House BUY Spouse 2020-07-28 2 days — $15K–$50K
0.1% of NW
90.9 ↗ filing
Lois Frankel House SELL Self 2020-06-09 0 days — $1K–$15K
0.3% of NW
40.4 ↗ filing
David McKinley House SELL Joint 2019-12-19 12 days — $15K–$50K 25.4 ↗ filing
Susie Lee House SELL Joint 2019-10-29 2 days — $1K–$15K
0.2% of NW
40.4 ↗ filing
Susie Lee House BUY Joint 2019-10-07 24 days — $1K–$15K
0.2% of NW
75.9 ↗ filing
Elizabeth Fletcher House SELL Self 2019-03-08 45 days — $1K–$15K
0.2% of NW
52.4 ↗ filing
David McKinley House SELL Self 2019-03-08 0 days — $1K–$15K 19.6 ↗ filing
Elizabeth Fletcher House SELL Spouse 2019-02-26 52 days — $1K–$15K
0.2% of NW
86.8 ↗ filing
David McKinley House BUY Self 2018-12-20 11 days — $1K–$15K 15.7 ↗ filing
Katherine Clark House SELL Spouse 2018-10-01 48 days — $1K–$15K
0.1% of NW
22.3 ↗ filing
Katherine Clark House SELL Spouse 2018-01-03 36 days — $1K–$15K
0.1% of NW
40.4 ↗ filing
Thomas Rooney House SELL Self 2017-09-22 9 days — $1K–$15K 15.7 ↗ filing
David McKinley House BUY Self 2017-09-14 16 days — $1K–$15K 22.3 ↗ filing
Frank LoBiondo House SELL Self 2017-05-17 20 days — $1K–$15K 75.9 ↗ filing
Katherine Clark House BUY Spouse 2017-04-04 48 days — $1K–$15K
0.1% of NW
75.9 ↗ filing
David McKinley House BUY Self 2016-12-27 7 days — $1K–$15K 40.4 ↗ filing
David McKinley House BUY Joint 2016-12-21 13 days — $15K–$50K 90.9 ↗ filing
Thomas Rooney House BUY Self 2016-11-02 30 days — $1K–$15K 22.3 ↗ filing
Thomas Rooney House BUY Self 2016-09-01 30 days — $1K–$15K 40.4 ↗ filing
Thomas Rooney House BUY Self 2016-06-01 30 days — $1K–$15K 75.9 ↗ filing
Robert Wittman House SELL Self 2015-01-15 15 days — $1K–$15K
0.2% of NW
75.9 ↗ filing
Lois Frankel House SELL Self 2014-10-08 0 days — $1K–$15K
0.3% of NW
75.9 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in CLX — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

3
Congress trades with insider convergence
4
…with insider divergence
13
Insider open-market trades

Of the congressional trades in CLX, 3 coincided with corporate insiders moving the same way within 60 days, and 4 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-05-05 Breber Pierre R Director BUY $429K ↗ EDGAR
2025-11-21 Breber Pierre R Director BUY $417K ↗ EDGAR
2025-09-04 Reynolds Eric H C-suite SELL $1.9M ↗ EDGAR
2025-05-07 Breber Pierre R Director BUY $546K ↗ EDGAR
2025-03-11 Marriner Kirsten C-suite SELL 10b5-1 $110K ↗ EDGAR
2025-03-10 Marriner Kirsten C-suite SELL 10b5-1 $3K ↗ EDGAR
2025-03-10 Marriner Kirsten C-suite SELL 10b5-1 $352K ↗ EDGAR
2025-03-10 Marriner Kirsten C-suite SELL 10b5-1 $355K ↗ EDGAR
2025-03-10 Marriner Kirsten C-suite SELL 10b5-1 $427K ↗ EDGAR
2024-12-16 Hilt Angela C C-suite SELL 10b5-1 $55K ↗ EDGAR
2024-12-16 Hilt Angela C C-suite SELL 10b5-1 $152K ↗ EDGAR
2024-09-06 Hilt Angela C C-suite SELL 10b5-1 $287K ↗ EDGAR
2023-08-14 Jacobsen Kevin B C-suite SELL 10b5-1 $538K ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
Congress 2026-05-15 Gilbert Cisneros SELL $1K–$15K
◆ insider 2026-05-05 Breber Pierre R Director BUY $429K
Congress 2025-12-19 Gilbert Cisneros BUY $1K–$15K
◆ insider 2025-11-21 Breber Pierre R Director BUY $417K
Congress 2025-11-12 Gilbert Cisneros SELL $1K–$15K
Congress 2025-10-30 Lisa McClain SELL $1K–$15K
Congress 2025-10-30 Lisa McClain BUY $1K–$15K
◆ insider 2025-09-04 Reynolds Eric H C-suite SELL $1.9M
Congress 2025-06-24 Lisa McClain BUY $1K–$15K
◆ insider 2025-05-07 Breber Pierre R Director BUY $546K
Congress 2025-04-11 Jefferson Shreve SELL $15K–$50K
◆ insider 2025-03-11 Marriner Kirsten C-suite 10b5-1 SELL $110K
◆ insider 2025-03-10 Marriner Kirsten C-suite 10b5-1 SELL $3K
◆ insider 2025-03-10 Marriner Kirsten C-suite 10b5-1 SELL $352K
◆ insider 2025-03-10 Marriner Kirsten C-suite 10b5-1 SELL $355K
◆ insider 2025-03-10 Marriner Kirsten C-suite 10b5-1 SELL $427K
◆ insider 2024-12-16 Hilt Angela C C-suite 10b5-1 SELL $55K
◆ insider 2024-12-16 Hilt Angela C C-suite 10b5-1 SELL $152K
◆ insider 2024-09-06 Hilt Angela C C-suite 10b5-1 SELL $287K
◆ insider 2023-08-14 Jacobsen Kevin B C-suite 10b5-1 SELL $538K
Congress 2022-02-22 Marjorie Taylor Greene BUY $1K–$15K
Congress 2022-02-07 Lois Frankel SELL $1K–$15K
Congress 2021-12-14 Carol Devine Miller SELL $15K–$50K
Congress 2021-06-26 Lois Frankel BUY $1K–$15K

FAQ Common questions

How much has Congress traded CLX?

17 disclosed buys and 20 sells of CLX (Clorox Co.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade CLX?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.